Allopregnanolone for the Treatment of Traumatic Brain Injury
Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
This study will provide initial data on the safety and effectiveness of allopregnanolone in
improving neurobehavioral outcome and reducing mortality in adults with moderate and severe
traumatic brain injury.
Phase:
Phase 2
Details
Lead Sponsor:
Michael A. Rogawski, MD, PhD University of California, Davis